WASHINGTON - The United States Food and Drug Administrations approval procedure for a questionable drug used to deal with Alzheimers was rife with abnormalities, a congressional report said Thursday.
Music
Trailers
DailyVideos
India
Pakistan
Afghanistan
Bangladesh
Srilanka
Nepal
Thailand
StockMarket
Business
Technology
Startup
Trending Videos
Coupons
Football
Search
Download App in Playstore
Download App
Best Collections